Keywords: NAFLD; NASH; Lipotoxicity; Free cholesterol; Cholesterol homeostasis; Liver;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ALT; alanine aminotransferase; AST; aspartate aminotransferase; BMI; body mass index; EGD; esophagoduodenoscopy; FXR; farnesoid X receptor; HCC; hepatocellular carcinoma; LDL; low-density lipoprotein; MRE; magnetic resonance elastography; NAFL; nonalcohol
Keywords: ASGE; American Society for Gastrointestinal Endoscopy; AT; aspiration therapy; BIB; BioEnterics Intragastric Balloon; BMI; body mass index; EBT; endoscopic bariatric therapy; ESG; endoscopic sleeve gastroplasty; FDA; U.S. Food and Drug Administration; %EW
Keywords: Prognostic Factor; Noninvasive Markers; Advanced Technology; Fibrosis Progression; ALT; alanine aminotransferase; APRI; aspartate aminotransferase-to-platelet ratio index; AST; aspartate aminotransferase; AUROC; area under the receiver operating character
Keywords: Bacterial translocation; Cirrhosis; Hepatitis; Liver diseases; Microbiota; Probiotics; GI; gastrointestinal; BECs; biliary epithelial cells; TLRs; Toll-like receptors; IL; interleukin; TNF; tumor necrosis factor; LPS; lipopolysaccharide; NF-κβ; nuclear
Keywords: ACC; acetyl-CoA carboxylase; ACL; ATP-citrate lyase; AMPK; 5â²-AMP-dependent protein kinase; Apc; adenomatous polyposis coli; BMAL1; brain and muscle Arnt-like 1; CCG; clock controlled genes; CLOCK; circadian locomotor output cycles kaput; CPT1/CPT2; car
Keywords: ACS; acyl-CoA synthetase; ACSVL; very-long-chain acyl-CoA synthetase; AP; alkaline phosphatase; AST; aspartate aminotransferase; ATF-2; activating transcription factor-2; Bax; Bcl-2 associated X protein; CE; cholesterol ester; Cer; ceramides; CerS; cerami
Keywords: NASH; Prognosis; PRELHIN Study; Prediction; BMI; body mass index; CI; confidence interval; CRN; Clinical Research Network; HCC; hepatocellular cancer; HR; hazard ratio; IQR; interquartile range; NAFLD; nonalcoholic fatty liver disease; NAS; nonalcoholic f
Keywords: ACS; acyl-coenzyme A synthase; adipoR; adiponectin receptor; ADP; adenosine diphosphate; AP2diph; attenuated P2 diphtheria toxin; AOX; acyl-coenzyme A oxidase; ApoE; apolipoprotein E; ATP; adenosine triphosphate; CBS; cystathionine-β-synthase; CD36; clus
Keywords: Fibrosis; Cirrhosis; Nonalcoholic Steatohepatitis; Fatty Liver; Natural History; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CI; confidence interval; FPR; fibrosis progression rate; I2; inconsistency index; NAFL; nonalcoholic fatty liv
Keywords: ALT; alanine aminotransferase; AMPK; AMP-activated protein kinase; AST; aspartate aminotransferase; CDAA diet; choline-deficient/l-amino acid-defined diet; GLP-2; glucagon-like peptide-2; HFD; high fat diet; IL-1; interleukin 1; IL-6; interleukin 6; Fiaf;
Keywords: Metabolic programming; Hepatic steatosis; Oxidative stress; Lipogenesis; β-Oxidation; Stereology; Mice; BM; body mass; CAT; catalase; CPT; carnitine palmitoyl-CoA transferase; DIO; diet-induced obesity; FAS; fatty acid synthase; FFA; free fatty acids; GP
Keywords: Liver Cirrhosis; Serum Markers; Imaging; ARFI; SWE; TE; Magnetic Resonance Imaging; Liver Stiffness; Elastography; Shear Wave; NAFLD Fibrosis Score; BARD; APRI; aspartate aminotransferase-to-platelet ratio; ARFI; acoustic radiation force impulse; AST/ALT;
Keywords: AMPK; 5â²-adenosine monophosphate-activated protein kinase; BMI; body mass index; CHB; chronic hepatitis B; CHC; chronic hepatitis C; ChREBP; carbohydrate response element binding protein; Fox; forkhead box protein; HCC; hepatocellular carcinoma; HSCs;
Keywords: Gene Expression; IL8; Immune Regulation; Inflammatory Response; ALT; alanine aminotransferase; AST; aspartate aminotransferase; AT; adipose tissue; ATM; adipose tissue macrophage; AUROC; area under receiver operating characteristic; BMI; body mass index;
Keywords: Pediatric; Severe Obesity; Microarray; Inflammation; ALT; alanine aminotransferase; BMI; body mass index; FC; fold change; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; Teen-LABS; Teen Longitudinal Assessment of Bariatric Su
Keywords: AOR; adjusted odds ratio; BMI; body mass index; CI; confidence interval; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; OR; odds ratio; Nonalcoholic fatty liver; Children; Ultrasonongraphy; Steatohepatitis; Secondhand smoke;
Keywords: CK-18; cytokeratin-18; NAFLD; nonalcoholic fatty liver disease; Apoptosis; Noninvasive biomarker; Ultrasonography scoring system;
Keywords: PNPLA; patatin-like phospholipase domain-containing protein; ADPN; adiponutrin; LPAAT; lysophosphatidic acid acyltransferaese; VLDL; very low density lipoprotein; ApoB100; Apolipoprotein B100; PPD; Plasma Proteome Database; CBS; Center of Biological Seque
Keywords: Mediterranean diet; Inflammatory markers; Transient elastography; Liver biopsy; ALT; alanine aminotransferase; AST; aspartate aminotransferase; BMI; body mass index; BIA; bioelectrical impedance analysis; FFQ; food frequency questionnaire; GGT; gamma-glut
Keywords: KCs; kupffer cells; JNKs; C-Jun N-terminal kinases; MAPKs; mitogen-activated protein kinases; CCR2; C-C motif chemokine receptor 2; ATMs; Adipose tissue macrophages; HFD; high-fat diet; MLK3; mixed-lineage kinase 3; PPAR; peroxisome proliferator-activat
Keywords: ACOX-1; acyl-CoA oxidase 1; AdipoQ; adiponectin; BCE; black currant extract; CD68; cluster of differentiation 68; CLS; crown-like structures; CTP-1; carnitine palmotyoltransferase 1; CVD; cardiovascular disease; DIO; diet-induced obesity; FAS; fatty acid
Keywords: HOMA-IR; homeostasis model assessment-insulin resistance; FPI; fasting plasma insulin; FPG; fasting plasma glucose; PFK-2; phosphofructokinase 2; NAFLD; non-alcoholic fatty liver disease; Fructokinase; Glucokinase; Glucose metabolism; Glycoxidative stress
Keywords: AKT; protein kinase B; ALT; alanine aminotransferase; AST; Aspartate aminotransferase; HDL; high-density lipoprotein; HFD; high-fat diet; iNOS; inducible nitric oxide synthase; IL; interleukin; ipGTT; intraperitoneal glucose tolerance test; ITT; insulin t
Keywords: TFs; transcription factors; GEO; Gene Expression Omnibus; FFA; free fatty acid; T2D; type 2 diabetes; IFG; impaired fasting glycemia; IGT; impaired glucose tolerance; CVD; cardiovascular diseases; HI clamp; hyperinsulinemic euglycemic clamp; SSPG; steady
Keywords: ASBT; apical sodium dependent transporter; AKT; protein kinase B; BSEP; bile salt export protein (ABCB11); CA; cholic acid; CCA; cholangiocarcinoma; CDCA; chenodeoxycholic acid; CYP7A1; cholesterol 7α-hydroxylase; CYP7B1; oxysterol 7α-hydroxylase; CYP27
Keywords: Key Indexing Terms; Oxidative stress; Lymphocytes; Metabolic syndrome; NAFLD; ROS;
Keywords: ALT; Alanine aminotransferase; AST; Aspartate aminotransferase; BMI; Body mass index; CART; Classification and regression tree; HDL; High-density lipoprotein; HgbA1c; Hemoglobin A1c; HOMA-IR; Homeostatic model assessment of insulin resistance; MRI; Magnet
Keywords: Nutrition; Polychlorinated biphenyls, PCBs; Serum carotenoids; NHANES, type 2 diabetes; Environmental health; A1C; glycosylated hemoglobin; AhR; Aryl hydrocarbon receptor; BMI; body mass index; CVD; cardiovascular disease; LOD; limit of detection; NAFLD;
Keywords: BMI; body mass index; CRP; C-reactive protein; FFA; free fatty acid; IR; insulin resistance; MHO; metabolically healthy obese; NAFLD; non-alcoholic fatty liver disease; WBC; white blood cell count; Obesity; Metabolically healthy obese (MHO); Insulin resis
Keywords: NAFLD; Non-alcoholic fatty liver disease; dG-TAM; (E)-α-(deoxyguanosin-N2-yl)-tamoxifen; dG-DesMeTAM; (E)-α-(deoxyguanosin-N2-yl)-N-desmethyltamoxifen; ALT; alanine transaminase; AST; aspartate transaminase; LDH; lactate dehydrogenase; α-SMA; α-smooth
Keywords: ALT; alanine aminotransferase; FC; free cholesterol; GREACE; Greek Artorvastatin and Coronary Heart Disease Evaluation; HDL; high-density lipoprotein; HMGCoA; 3-hydroxy-3-methylglutaryl-coenzyme A; LDL; low-density lipoprotein; NAFLD; nonalcoholic fatty
Keywords: Lipid Metabolism; Fatty Acid Kinetics; Obesity; Diabetes; FA; fatty acid; FFA; free (nonesterified) fatty acid; HighLF; high levels of liver fat; LowLF; low levels of liver fat; NAFLD; nonalcoholic fatty liver disease; RaFFA; rate of appearance of adipose
Keywords: Interleukin-6 (IL-6); Metabolic disease; IL-6; interleukin-6; MS; metabolic syndrome; ROS; reactive oxygen species; IFN; interferon; hIL-6; human interleukin-6; SHP-2; Src homology domain-containing protein tyrosine phosphatase-2; IR; insulin resistance;
Keywords: α-SMA; alpha-smooth muscle actin; ALT; alanine aminotransferase; DAB; 3,3â²-diaminobenzidine; ECL; enhanced chemiluminescence; GS; glutamine synthase; hMSC; human mesenchymal stem cells; HRP; horse radish peroxidase; LCN2; Lipocalin 2; MCD; methionine-
Keywords: Physical activity; Membrane; Phospholipids; Fatty acids; NAFLD;
Keywords: BMI; body mass index; CT; computed tomographic; HDL; high-density lipoprotein; HS-CRP; high-sensitivity C-reactive protein; L/S; liver/spleen attenuation; MESA; Multi-Ethnic Study of Atherosclerosis; NAFLD; nonalcoholic fatty liver disease; ROI; region of
Keywords: ABCA1; ATP binding cassette transporter A1; Actb; beta-actin; ApoA-I; apolipoprotein A-I; B2m; beta-2 microglobulin; Cyp2E1; cytochrome P450 2E1; FXR; farnesoid X receptor; Gapdh; glyceraldehyde-3-phosphate dehydrogenase; GLUT1; glucose transporter 1; HDL
Keywords: ASA; acetylsalicylic acid; CE; capsule endoscopy; GI; gastrointestinal; IBD; inflammatory bowel disease; IBS; irritable bowel syndrome; NAFLD; nonalcoholic fatty liver disease; NSAID; nonsteroidal anti-inflammatory drug; PPI; proton pump inhibitor; SIBO;
Keywords: ALT; alanine aminotransferase; ApoAI; apolipoprotein AI resp. ApoAII, ApoCII, ApoCIII; AST; aspartate aminotransferase; CRP; C-reactive protein; DGLA; dihomo-gamma-linolenic acid; FFA; free fatty acid; GGT; gamma glutamyltransferase; IL-6; interleukin-6;
Keywords: Training; Physical activity; NAFLD; Hepatic; Mitochondria;
Keywords: BHB; β-hydroxybutyrate; en%; energy percent; g%; gram percent; HF; high fat (42 en%); HP; high protein (35 en%); HPX; high protein (58 en%); LF; low fat (8 en%); LP; low protein (11 en%); mmBCFA; monomethyl branched-chain fatty acid; NAFLD; nonalcoholic
Keywords: AIH; autoimmunelike hepatitis; ALF; acute liver failure; ALT; alanine aminotransferase; CNS; central nervous system; DI-AIH; drug-induced autoimmunelike hepatitis; DILI; drug-induced liver injury; DILIN; Drug Induced Liver Injury Network; FDA; Food and Dr
Keywords: CD36/FAT; fatty acid translocase; CerS; ceramide synthase; DRMs; detergent resistant membranes; FABP; fatty acid binding protein; FABPpm; plasma membrane fatty acid binding protein; FATP; fatty acid transport protein; FFA; free fatty acid; HFD; high fat d
Keywords: Acaca; Acetyl-Coenzyme A carboxylase 1; Acly; ATP citrate lyase; Actb; Beta-actin; ANOVA; Analysis of variance; AUC; Area under the curve; Bax; Bcl2-associated X protein; Bcl2; B cell leukemia/lymphoma 2; Bscl2; Berardinelli-Seip congenital lipodystroph
Keywords: Exercise; Diet; Adherence; Behavior; Function; NAFLD;
Keywords: NAFLD; NASH; Epidemiology; Diagnosis; Treatment;
Keywords: NAFLD; Obesity-Related Fatty Liver; Chronic Disease; ALT; AST; ALT; alanine aminotransferase; AMPK; adenosine monophosphate-activated kinase; ANOVA; analysis of variance; AST; aspartate aminotransferase; AT-IR; adipose tissue insulin resistance index; C
Keywords: ADH; alcohol dehydrogenase; AH; acute alcoholic hepatitis; ALD; alcoholic liver disease; ALT; alanine aminotransferase; ASH; alcoholic steato-hepatitis; AST; aspartate aminotransferase; CDT; carbohydrate-deficient transferrin; CYP; cytochrome p450; GAA; g
Keywords: AAV1; adeno-associated virus serotype 1; ACC; American College of Cardiology; ACCELERATE; A Study of Evacetrapib in High-Risk Vascular Disease; ACCORD; Action to Control Cardiovascular Risk in Diabetes; ADA; American Diabetes Association; AMP; adenosine m